Poster Presentations 2017
DOI: 10.1136/annrheumdis-2017-eular.4967 View full text |Buy / Rent full text
|
|

Abstract: BackgroundThe development of the 2010 classification criteria for rheumatoid arthritis (RA) has led to a redefinition of the patient population, including classification of seropositive versus seronegative patients. In our recently published study of DMARD naïve early RA patients fulfilling the 2010 ACR/EULAR criteria, we found seronegative patients to have markedly higher disease activity at time of diagnosis, compared to seropositive patients.[1] There is very limited information about the disease course of … Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
1
0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

0
1
0
Order By: Relevance
“…Patients were assessed at 13 visits during two years of follow-up. [2] We stratified the patients as seropositive (rheumatoid factor (RF)+, anti-citrullinated peptide antibody (ACPA)+, or both) or seronegative (RFand ACPA-). At 24-month follow-up, measures of disease activity were compared across the groups using independent samples t-test, Mann-Whitney U test or chi square test as appropriate.…”
Section: Friday 16 June 2017mentioning
Create an account to read the remaining citation statements from this report. You will also get access to:
  • Search over 1b+ citation statments to see what is being said about any topic in the research literature
  • Advanced Search to find publications that support or contrast your research
  • Citation reports and visualizations to easily see what publications are saying about each other
  • Browser extension to see Smart Citations wherever you read research
  • Dashboards to evaluate and keep track of groups of publications
  • Alerts to stay on top of citations as they happen
  • Automated reference checks to make sure you are citing reliable research in your manuscripts
  • 14 day free preview of our premium features.

Trusted by researchers and organizations around the world

Over 100,000 students researchers, and industry experts at use scite

See what students are saying

rupbmjkragerfmgwileyiopcupepmcmbcthiemesagefrontiersapsiucrarxivemeralduhksmucshluniversity-of-gavle
“…Patients were assessed at 13 visits during two years of follow-up. [2] We stratified the patients as seropositive (rheumatoid factor (RF)+, anti-citrullinated peptide antibody (ACPA)+, or both) or seronegative (RFand ACPA-). At 24-month follow-up, measures of disease activity were compared across the groups using independent samples t-test, Mann-Whitney U test or chi square test as appropriate.…”
Section: Friday 16 June 2017mentioning